ADVANCE trial suggests routine antihypertensive treatment in diabetes

The Action in Diabetes and Vascular disease: preterAx and diamicroN-MR Controlled Evaluation (ADVANCE) trial assessed the effects of the routine administration of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type II diabetes, irrespective of initial blood pressure levels or the use of other blood pressure lowering agents.

by

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package